Nanotechnology 'supercharges' immune system molecules to fight cancer
Researchers from Cytimmune Sciences, a clinical-stage biotech company, have presented new data on the company's novel cancer nanomedicines.
Source: labiotech.eu
Stay updated with breaking news from Cytimmune Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Researchers from Cytimmune Sciences, a clinical-stage biotech company, have presented new data on the company's novel cancer nanomedicines.